Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter …

P Paolisso, L Bergamaschi, G Santulli… - Cardiovascular …, 2022 - Springer
Background The inflammatory response occurring in acute myocardial infarction (AMI) has
been proposed as a potential pharmacological target. Sodium-glucose co-transporter 2 …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive …

HR Reynolds, A Maehara, RY Kwong, T Sedlak… - Circulation, 2021 - Am Heart Assoc
Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) occurs in
6% to 15% of myocardial infarctions (MIs) and disproportionately affects women. Scientific …

Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction

P Severino, A D'Amato, M Pucci, F Infusino… - International journal of …, 2020 - mdpi.com
Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …

Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association

GN Levine, JW McEvoy, JC Fang, C Ibeh… - Circulation, 2022 - Am Heart Assoc
Despite the many advances in cardiovascular medicine, decisions concerning the
diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain …

Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials

U Zeymer, A Freund, M Hochadel, P Ostadal… - The Lancet, 2023 - thelancet.com
Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

M Valgimigli, F Gragnano, M Branca, A Franzone… - Bmj, 2021 - bmj.com
Objective To assess the risks and benefits of P2Y 12 inhibitor monotherapy compared with
dual antiplatelet therapy (DAPT) and whether these associations are modified by patients' …

Investigation of the associations of novel inflammatory biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)—With the …

EA Dziedzic, JS Gąsior, A Tuzimek, J Paleczny… - International Journal of …, 2022 - mdpi.com
Atherosclerosis, the underlying cause of coronary artery disease (CAD), has a significant
inflammatory component. White blood cell count is an affordable and accessible way to …

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

M Galli, S Benenati, D Capodanno, F Franchi, F Rollini… - The Lancet, 2021 - thelancet.com
Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …

[引用][C] 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - Oxford University Press (OUP)